Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUOXETINE Cause Interstitial lung disease? 108 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Interstitial lung disease have been filed in association with FLUOXETINE (Fluoxetine). This represents 0.4% of all adverse event reports for FLUOXETINE.

108
Reports of Interstitial lung disease with FLUOXETINE
0.4%
of all FLUOXETINE reports
12
Deaths
67
Hospitalizations

How Dangerous Is Interstitial lung disease From FLUOXETINE?

Of the 108 reports, 12 (11.1%) resulted in death, 67 (62.0%) required hospitalization, and 18 (16.7%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUOXETINE. However, 108 reports have been filed with the FAERS database.

What Other Side Effects Does FLUOXETINE Cause?

Toxicity to various agents (3,172) Drug ineffective (2,471) Completed suicide (2,345) Drug interaction (2,054) Intentional overdose (2,026) Foetal exposure during pregnancy (1,670) Off label use (1,472) Serotonin syndrome (1,457) Suicide attempt (1,441) Anxiety (1,347)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which FLUOXETINE Alternatives Have Lower Interstitial lung disease Risk?

FLUOXETINE vs FLUOXETINE\FLUOXETINE FLUOXETINE vs FLUOXETINE\OLANZAPINE FLUOXETINE vs FLUPENTIXOL FLUOXETINE vs FLUPENTIXOL DECANOATE FLUOXETINE vs FLUPHENAZINE

Related Pages

FLUOXETINE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease FLUOXETINE Demographics